Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.61 |
| ▸ | HTT | P42858 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.61 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.61 |
| ▸ | MIF | P14174 | 1/20 | 0.61 |
| ▸ | TYR | P14679 | 1/20 | 0.61 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.54 |
| ▸ | ATP2A3 | Q93084 | 1/20 | 0.54 |
| ▸ | NR1H4 | Q96RI1 | 6/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11317922 | 0.86 | HSD17B10 (0.50) | ALDH1A1ALOX15HSD17B10HTTLMNA | |
| SCHEMBL818330 | 0.84 | HSD17B10 (0.48) | ALDH1A1ALOX15HSD17B10HTTLMNA | |
| SCHEMBL8389745 | 0.83 | HSD17B10 (0.48) | ALDH1A1ALOX15HSD17B10HTTLMNA | |
| SCHEMBL2789834 | 0.82 | ALDH1A1 (0.54) | ALDH1A1ALOX15HSD17B10HTTLMNA | |
| SCHEMBL12804190 | 0.79 | HSD17B10 (0.43) | ALDH1A1ALOX15HSD17B10HTTLMNA | |
| SCHEMBL30553151 | 0.79 | ALOX15 (0.44) | ALDH1A1ALOX15HSD17B10HTTLMNA | |
| SCHEMBL2437476 | 0.79 | ALOX15 (0.44) | ALDH1A1ALOX15HSD17B10HTTLMNA | |
| SCHEMBL11588522 | 0.79 | ALDH1A1 (0.48) | ALDH1A1ALOX15HSD17B10HTTLMNA | |
| SCHEMBL8044336 | 0.79 | NR1H4 (0.43) | ALDH1A1ALOX15HSD17B10HTTLMNA | |
| SCHEMBL13403326 | 0.78 | MAPK1 (0.46) | ALDH1A1ALOX15HSD17B10HTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122037020-A | Supported catalyst, preparation method thereof and application thereof in olefin polymerization | 中国石油化工股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-1185240-C | Process for one-stage synthesizing substituted diaryl organic metal phosphate | SHANGHAI SHENGLIN NEW MATERIAL (CN) | 2005-01-19 | — | — | CN | claimed |
| CN-1358728-A | Process for one-stage synthesizing substituted diaryl organic metal phosphate | SHANGHAI CHENGLIN NEW MATERIAL (CN) | 2002-07-17 | — | — | CN | claimed |
| CN-122037020-A | Supported catalyst, preparation method thereof and application thereof in olefin polymerization | 中国石油化工股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-119118988-B | Method for degrading poly L-lactic acid into L-lactide | 苏州大学 | 2025-04-04 | — | — | CN | disclosed |
| CN-119118988-A | Method for degrading poly L-lactic acid into L-lactide | 苏州大学 | 2024-12-13 | — | — | CN | disclosed |
| US-12030853-B2 | MASP-2 inhibitors and methods of use | OMEROS CORPORATION (US) | 2024-07-09 | — | — | US | disclosed |
| US-12030853-B2 | MASP-2 inhibitors and methods of use | OMEROS CORPORATION (US) | 2024-07-09 | — | — | US | disclosed |
| CN-112679635-B | Preparation method of supported metallocene catalyst and catalyst prepared by preparation method | 中国石油化工股份有限公司 | 2024-03-26 | — | — | CN | disclosed |
| US-11807641-B2 | MASP-2 inhibitors and methods of use | OMEROS CORPORATION (US) | 2023-11-07 | — | — | US | disclosed |
| US-11807641-B2 | MASP-2 inhibitors and methods of use | OMEROS CORPORATION (US) | 2023-11-07 | — | — | US | disclosed |
| EP-1015518-A1 | ISOXINDIGOS USEFUL AS COLORANTS AND PREPARATION THEREOF | Ciba SC Holding AG (CH) | 2000-07-05 | — | — | EP | disclosed |
| WO-1999052909-A2 | DIBENZONAPHTHYRONES AND THEIR USE FOR COLOURING/PIGMENTING HIGH-MOLECULAR-WEIGHT ORGANIC MATERIAL | CIBA SPECIALTY CHEMICAL HOLDING INC. (CH) | 1999-10-21 | — | — | WO | disclosed |
| WO-1999013007-A1 | ISOXINDIGOS USEFUL AS COLORANTS AND PREPARATION THEREOF | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1999-03-18 | — | — | WO | disclosed |
| EP-0282294-B1 | Vinylsilylalkoxy arylbenzotriazole compounds and UV absorbing compositions made therefrom | IOLAB CORP (US) | 1993-12-01 | — | — | EP | disclosed |
| EP-0283166-B1 | 2-(2'-HYDROXYPHENYL)-5(6) (ACRYLOYLOXYALKOXY)-BENZOTRIAZOLE AND ULTRAVIOLET ABSORBING POLYMERS THEREFROM | IOLAB CORPORATION (US) | 1992-01-02 | — | — | EP | disclosed |
| US-4803254-A | Vinylsilylalkoxy arylbenzotriazole compounds and UV absorbing compositions made therefrom | IOLAB CORPORATION (US) | 1989-02-07 | — | — | US | disclosed |
| EP-0283166-A1 | 2-(2'-Hydroxyphenyl)-5(6) (acryloyloxyalkoxy)-benzotriazole and ultraviolet absorbing polymers therefrom | IOLAB CORPORATION (US) | 1988-09-21 | — | — | EP | disclosed |
| EP-0282294-A2 | Vinylsilylalkoxy arylbenzotriazole compounds and UV absorbing compositions made therefrom | IOLAB CORPORATION (US) | 1988-09-14 | — | — | EP | disclosed |
| US-3933927-A | Phenol transalkylation process | ETHYL CORPORATION (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11807641-B2 | MASP-2 inhibitors and methods of use | MASP2, METAP2, SPINT2 | ALDH1A1 4709/4885ALOX15 3975/4885HSD17B10 3100/4885 |
| US-12030853-B2 | MASP-2 inhibitors and methods of use | MASP2, METAP2, SPINT2 | ALDH1A1 4709/4885ALOX15 3975/4885HSD17B10 3100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.